This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis
Experimental Hematology & Oncology Open Access 28 August 2022
-
Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells
Cancer Cell International Open Access 24 May 2020
-
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies
Diagnostic Pathology Open Access 22 December 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144–1148.
Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779–1790.
Storlazzi CT, Anelli L, Albano F, Zagaria A, Ventura M, Rocchi M et al. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1. Ann Hematol 2004; 83: 78–83.
Borrmann L, Wilkening S, Bullerdiek J . The expression of HMGA genes is regulated by their 3'UTR. Oncogene 2001; 20: 4537–4541.
Stenman G . Fusion oncogenes and tumor type specificity – insights from salivary gland tumors. Semin Cancer Biol 2005; 15: 224–235.
Andrieux J, Demory JL, Dupriez B, Quief S, Plantier I, Roumier C et al. Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes Cancer 2004; 39: 82–87.
Odero MD, Grand FH, Iqbal S, Ross F, Roman JP, Vizmanos JL et al. Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia 2005; 19: 245–252.
Fu CA, Shen M, Huang BC, Lasaga J, Payan DG, Luo Y . TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton. J Biol Chem 1999; 274: 30729–30737.
Acknowledgements
This work has been supported by AIRC (Associazione Italiana per la Ricerca sul Cancro), MIUR (Ministero dell’Istruzione, dell’Università e della Ricerca). We thank Dr P Iuzzolino and Dr G Piccolini for their contribution to the study, and Ms MVC Pragnell, BA, for language revision of this paper.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Storlazzi, C., Albano, F., Locunsolo, C. et al. t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene. Leukemia 20, 2190–2192 (2006). https://doi.org/10.1038/sj.leu.2404418
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404418
This article is cited by
-
The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis
Experimental Hematology & Oncology (2022)
-
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele
Leukemia (2021)
-
Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells
Cancer Cell International (2020)
-
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies
Diagnostic Pathology (2018)
-
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing
Diagnostic Pathology (2016)